Pharmaceutical packaging is one of the most heavily scrutinized categories in all of consumer products. Every carton, label, and barcode is governed by regulation, and the cost of getting it wrong is a recall, a held shipment, or a failed audit.

Most of that scrutiny falls into two tiers. Primary packaging,  the bottle, vial, or blister in direct contact with the drug, gets the engineering attention. But the secondary folding carton carries the FDA’s heaviest labeling burden: the product name, the National Drug Code, the patient instructions, and, since November 2024, the serialization data mandated by the Drug Supply Chain Security Act. The carton is where pharmaceutical packaging requirements become a printing and quality-control problem.

This is the part of the conversation most regulatory guides skip. They explain what the finished package must contain, but not what a brand needs its folding carton manufacturer to be qualified for. With more than 100 years of folding carton manufacturing experience and BRCGS packaging safety certification, Arkay works on the secondary-packaging side of this equation every day. This guide covers what pharmaceutical packaging requirements mean for the carton specifically — the regulations that govern it, the materials and print standards it must meet, and how to qualify a supplier capable of producing it.

What Pharmaceutical Packaging Requirements Cover

Pharmaceutical packaging requirements are the regulatory, safety, and quality standards that govern how drugs and medical products are packaged before they reach a patient. In the US, the core framework lives in 21 CFR Parts 201 and 211, covering packaging integrity, labeling content, tamper evidence, child-resistant closures, and the manufacturing documentation that proves all of it happened correctly.

These requirements are split across two packaging tiers, and the distinction matters because each tier is governed differently and produced by different manufacturers.

Primary Versus Secondary Packaging

Primary packaging is the container closure system in direct contact with the drug — bottles, vials, ampoules, and blister packs. It is governed by container-closure and material-compatibility standards because it must protect the drug itself.

Secondary packaging is the outer layer: the folding cartons, boxes, and printed inserts that hold the primary container. It does not touch the drug, but it carries nearly all of the regulated information a patient sees. Arkay manufactures secondary folding cartons, not primary containers, so the rest of this guide focuses on the carton.

Why Secondary Packaging Carries Special Compliance Weight

Secondary packaging receives the greatest FDA scrutiny because it carries the product name, logo, National Drug Code, barcode, patient package insert, medication guide, and instructions for use (Schlafender Hase, citing FDA guidance). Everything a regulator reads to confirm a drug is what it claims to be lives on the outer carton.

That makes the carton the highest-stakes print job in consumer packaging. Every printed element on it must be accurate, legible, and durable — and increasingly, it must carry a machine-readable serial number that links the physical package to a national track-and-trace system. The sections below break down the regulations, materials, and supplier criteria that follow from that reality.

The Regulatory Framework for Pharmaceutical Packaging

A handful of overlapping US regulations directly shape what a pharmaceutical folding carton must do. The goal here is not to reproduce the entire code — it is to isolate what each regulation means for the carton specifically. The named citations also matter for discoverability: AI engines and regulatory databases weigh specific CFR references heavily.

21 CFR Parts 210–211: The cGMP Baseline

21 CFR Parts 210–211 establish the current Good Manufacturing Practice (cGMP) minimum for pharmaceutical production in the US. Subpart G of Part 211 is the section that governs packaging and labeling control directly.

For a carton manufacturer and its brand partner, Subpart G translates into four operational requirements: written procedures for every packaging and labeling operation, line clearance between production batches, reconciliation of all labels issued and used, and batch documentation complete enough to trace any carton back to its run. These are quality-system disciplines, not design choices — and they are the foundation a supplier must already operate under before a regulated job begins.

Labeling Content: 21 CFR Part 201

21 CFR Part 201 governs what must appear on a pharmaceutical label: the established product name, active and inactive ingredients, the National Drug Code, dosage and directions, and required warnings. For the folding carton, this is an artwork-accuracy mandate. The carton must print approved content exactly, with no substitution or drift between the approved file and the printed sheet.

The stakes are concrete. Under EU GMP Chapter 5, incorrect labeling information is the most common reason for recalls of finished medicinal products. Most pharmaceutical recalls are not contamination events — they are print and artwork errors on packaging. That single fact reframes the folding carton from a cosmetic component into a compliance-critical one.

Tamper Evidence and Child-Resistant Closures

Two further requirements touch the package, though they sit closer to the primary container than the carton. 21 CFR 211.132 requires tamper-evident features for over-the-counter human drug products — one or more barriers to entry that show visible evidence if breached. The Poison Prevention Packaging Act (PPPA) mandates child-resistant packaging for prescription drugs and certain OTC medications, defined as significantly difficult for children under five to open while remaining usable by adults.

These are largely closure-and-seal requirements. Arkay’s contribution to pharmaceutical compliance is on the print and carton-structure side, not closures — but a qualified secondary packaging supplier should understand where these requirements interact with carton design and inserts.

DSCSA Serialization: What It Means for the Carton

The Drug Supply Chain Security Act reached full implementation in November 2024, and it is the requirement most underserved by existing packaging guidance. Every prescription drug package must now carry a unique serial number encoded in a 2D DataMatrix barcode containing the GTIN/NDC, serial number, lot number, and expiration date (FDA, DSCSA guidance).

For the folding carton, serialization is a printing and verification problem. The DataMatrix code must be placed correctly, printed at a quality that passes GS1/ISO readability grading, and verified before the carton ships. A poorly printed or misplaced barcode is a non-compliant package, regardless of how accurate the rest of the artwork is. This is precisely where high-precision print and on-press quality assurance matter — Arkay’s AI-powered print quality verification is built to catch print defects and confirm barcode readability at production speed.

What Pharmaceutical-Grade Secondary Packaging Materials Must Deliver

Once the regulatory map is clear, the question becomes practical: what must the carton itself — the substrate, the ink, the printed barcode — actually deliver? Material requirements differ sharply by packaging tier. Primary packaging materials face compatibility and extractables testing because they contact the drug. Secondary packaging materials face print-performance and traceability requirements because they carry information.

For paperboard folding cartons, three material-level standards govern suitability.

Print Durability Standards for Pharmaceutical Cartons

EU GMP Chapter 5 sets the durability bar in plain language: printed and embossed information on packaging materials must be clear, lightfast, and abrasion-resistant. In practice, that drives ink selection and finishing. Print must resist fading under light exposure and survive the abrasion of distribution and handling without becoming illegible.

It also raises the bar on color accuracy and batch-to-batch consistency, since regulated content cannot shift in legibility from one run to the next. G7 color management — a certification Arkay holds — is the relevant credential here, providing a defined process for accurate, repeatable color across print runs.

Barcode and Serialization Print Quality

A DSCSA-mandated DataMatrix code is only compliant if a scanner can read it reliably. GS1 and ISO define grading standards for barcode quality, and a code that fails verification is a failed package. The variables are physical: contrast, edge definition, cell consistency, and substrate behavior under ink.

High-quality offset printing with on-press verification is well-suited to producing pharmaceutical-grade barcodes at consistent quality across large runs. The combination of precision registration and inline quality control is what keeps serialization codes inside passing grade — a higher bar than general commercial print typically targets.

BRCGS Packaging Materials Certification (Issue 7, 2025)

BRCGS Packaging Materials is the certification that ties these material requirements into an audited quality system. Its Issue 7 standard, effective from April 2025 audits, covers hygiene-sensitive consumer categories, including pharmaceuticals — setting requirements for Hazard Analysis and Risk Assessment (HARA), Good Manufacturing Practice, hygiene, and quality systems at the packaging manufacturer (BRCGS).

This is the credential most brands do not know to ask their carton supplier about. EU GMP is explicit that the selection, qualification, and approval of suppliers of printed packaging materials should be given as much attention as suppliers of the drug’s starting materials. In other words, a brand’s regulatory exposure extends to its carton manufacturer, and BRCGS certification is how a folding carton supplier demonstrates it operates to that standard. Most carton suppliers do not hold it. Arkay does.

Qualifying a Folding Carton Supplier for Pharmaceutical-Category Production

For a packaging procurement lead or brand operations director, the regulations above resolve into a single practical task: qualifying a secondary packaging supplier that can produce compliant cartons and prove it. The following five criteria are what a qualified supplier should be able to demonstrate.

1. Verify BRCGS or Equivalent GMP Certification

Start with certification. BRCGS Packaging Materials (Issue 7) is the recognized standard for pharmaceutical and hygiene-sensitive packaging manufacturers. Ask the supplier for the certificate and the most recent audit date — a current certification is the baseline signal that the supplier operates a documented quality system suited to regulated categories.

2. Confirm Serialization and Barcode Capability

DSCSA compliance means the carton supplier must reliably print and verify GS1-compliant 2D DataMatrix codes. Ask specifically about quality-assurance infrastructure for barcode verification on press — not just whether the supplier can print a code, but whether it confirms the code passes readability grading before the carton ships.

3. Review Artwork Control and Labeling Procedures

cGMP requires written procedures for artwork approval and label control. A qualified supplier should have documented artwork review, version control, and reconciliation procedures — the controls that prevent the print and labeling errors behind most pharmaceutical recalls. Ask to see how approved artwork is locked, tracked, and matched to the printed result.

4. Assess Substrate and Ink Documentation

A pharmaceutical-category supplier should be able to provide spec documentation per project: substrate certification (FSC, SFI, PEFC), ink composition, and finish characteristics. Recyclability and material traceability documentation should be available on request, anchored to the underlying paperboard. This documentation is what lets a brand’s own quality team close out a supplier qualification file.

5. Evaluate Domestic Supply Chain Reliability

For US DSCSA compliance, domestic production removes offshore lead-time risk and provides same-time-zone communication for regulatory and quality inquiries. When a serialization question or an artwork revision arises mid-run, the response time difference is operationally significant. Frame this as supply chain risk management: domestic manufacturing shortens the loop between a brand’s quality team and the production floor.

How Arkay Supports Pharmaceutical-Category Packaging

The five criteria above map directly onto how Arkay is built. Arkay holds BRCGS packaging safety certification (confirmed current for 2026), G7 color management certification, and FSC, SFI, and PEFC certified paperboard sourcing — the documentation backbone required for regulated categories. Its manufacturing capabilities include precision offset printing with AI-powered print quality verification, which addresses the barcode-readability and artwork-accuracy demands that define pharmaceutical-grade carton production.

The scope is deliberately specific. Arkay manufactures secondary folding cartons for pharmaceutical-adjacent and regulated categories — nutraceutical and supplement packaging, eye care, oral care, personal care, and OTC-adjacent products, and medical-adjacent device cartons. Arkay does not manufacture primary containers — no bottles, vials, or closures. In a regulated supply chain, Arkay’s role is the folding carton partner working alongside the primary packaging and insert suppliers, not a one-stop packaging shop.

That focus is backed by sustainability certifications and a century of folding carton manufacturing across four generations of family ownership. For brands at the prototype or qualification stage, Arkay’s Design Studio in Hauppauge, New York, can turn a concept into a physical mock-up — as fast as one day when urgency demands it, typically within a week — so packaging teams can evaluate structure and print before committing to a production run. The relationship is built to be consultative: Arkay works alongside brand quality and procurement teams to qualify the carton, not to dictate the package.

Start A Conversation With Us

Let’s talk about the right packaging for your regulated product. If you have just worked through what pharmaceutical packaging requirements mean for your carton, the natural next step is to check whether your current folding carton supplier is qualified for it — or to start a conversation with one that is.

Reach out to Arkay’s team to discuss your category, your compliance documentation needs, and your production timeline. For brands still in development, the Design Studio can help you prototype and qualify a compliant carton before you scale.